What markers track chronotype?
Chronotype is a behavioural proxy for circadian phase. This page outlines the research models and candidate markers used to track it, including melatonin timing, core body temperature, and metabolic signatures.
Chronotype is the behavioural expression of an individual's endogenous circadian phase — commonly operationalised as morningness–eveningness and measured by self-report instruments such as the Morningness–Eveningness Questionnaire (MEQ) or the Munich ChronoType Questionnaire (MCTQ). It is not a single molecule and has no sequence, formula, or molecular weight; it is a latent trait inferred from the timing of sleep, activity, and physiology. In research settings, chronotype is treated as a grouping variable against which candidate markers are compared.
The work centres on the circadian timing system — the suprachiasmatic nucleus and its peripheral clocks — and on the melatonin and core-temperature rhythms that index circadian phase.
Research Studies
Dim light melatonin onset and circadian phase in evening chronotypes
Dim light melatonin onset (DLMO) is widely used as the gold-standard phase marker in circadian research. In evening chronotypes, DLMO occurs later relative to clock time than in morning types, and the interval between DLMO and habitual sleep onset is used to estimate circadian misalignment. The marker is a timing measure, not a quantity of melatonin produced.
Core body temperature minimum and chronotype classification
The core body temperature minimum is another phase reference point, typically occurring in the latter half of the sleep episode. Studies comparing morning and evening chronotypes report that the temperature minimum is shifted later in evening types, consistent with a delayed circadian phase. Because temperature is influenced by activity and ambient conditions, it is usually measured under controlled laboratory protocols.
Exercise timing and glycaemic handling in prediabetes
A registered clinical trial is examining whether a single session of morning versus evening exercise differentially affects glucose handling in adults with prediabetes who have an extreme chronotype [1]. The design compares no-exercise, morning-exercise, and evening-exercise conditions within the same participant, with at least 14 days between test days [1]. This is a within-participant design, so each person serves as their own control.
CBT-I and bright light therapy in adolescents with ADHD and evening chronotype
A separate trial is evaluating cognitive behavioural therapy for insomnia (CBT-I), with or without bright light therapy, in adolescents with ADHD, insomnia, and an evening chronotype [2]. The rationale is that ADHD in this population is commonly accompanied by insomnia and circadian delay, and that these co-occurring disturbances may affect daytime functioning [2]. The study tests whether the combination addresses both the sleep and circadian components.
Exercise timing and performance in athletes and active adults
A structured narrative review synthesised evidence on morning versus afternoon or evening training in athletes and physically active adults, integrating performance outcomes with internal load, autonomic recovery, sleep interaction, and downstream physiological stress [3]. Acute evidence generally supported superior late-afternoon or early-evening performance, particularly for neuromuscular tasks, whereas chronic training studies did not indicate a universal optimal training time [3]. The review treats time of day as a programming variable rather than a scheduling constraint [3].
Nocturia, sleep parameters, and chronotype in women with urinary incontinence
A clinical study is examining the effect of nocturia on pelvic floor symptoms, sleep parameters, and quality of life in women with urinary incontinence [4]. Nocturia is defined as the number of urinations during the main sleep period, accompanied by the intention to fall back asleep after waking [4]. The study notes that nocturia can arise from sleep disorders and circadian rhythm disturbances, and that chronotype varies between individuals [4].
Metabolic signatures of sleep health and stroke risk
A prospective cohort study of 200,729 UK Biobank participants investigated whether a nuclear magnetic resonance-derived metabolic signature mediates the association between healthy sleep and lower stroke risk [5]. The work is relevant to chronotype research because it treats sleep health as a composite exposure and searches for circulating metabolites that track it. The findings are observational and do not establish that any metabolite causes or prevents stroke [5].
Comparison of candidate chronotype markers
| Marker | What it indexes | Typical use |
|---|---|---|
| MEQ / MCTQ score | Self-reported morningness–eveningness | Population screening, grouping variable |
| DLMO | Circadian phase | Laboratory phase assessment |
| Core body temperature minimum | Circadian phase | Controlled laboratory protocols |
| NMR-derived metabolic signature | Composite sleep health | Large cohort epidemiology [5] |
If you are reading this for personal health reasons
The materials described here are sold for laboratory research only, and we do not provide dosing or medical guidance. Nothing on this page is a recommendation for personal use. Anyone considering a compound for themselves should speak to a licensed clinician.
Sources
- [1] Exercise, Chronotype, and Prediabetes
- [2] Efficacy of Cognitive Behavioural Therapy for Insomnia and Bright Light Therapy in Adolescents With ADHD, Insomnia, and Evening Chronotype
- [3] Exercise Timing in Sport: Molecular and Physiological Mechanisms Linking Performance, Recovery, and Biological Cost
- [4] Examination of the Effect of Nocturia on Pelvic Floor Symptoms, Sleep Parameters and Quality of Life in Women With Urinary Incontinence
- [5] Metabolic signatures of sleep health and stroke risk: A prospective cohort study with mediation analysis